【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Pulmonary Arterial Hypertension Overview 8
Therapeutics Development 9
Pipeline Products for Pulmonary Arterial Hypertension – Overview 9
Pipeline Products for Pulmonary Arterial Hypertension – Comparative Analysis 10
Pulmonary Arterial Hypertension – Therapeutics under Development by Companies 11
Pulmonary Arterial Hypertension – Therapeutics under Investigation by Universities/Institutes 15
Pulmonary Arterial Hypertension – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Pulmonary Arterial Hypertension – Products under Development by Companies 19
Pulmonary Arterial Hypertension – Products under Investigation by Universities/Institutes 23
Pulmonary Arterial Hypertension – Companies Involved in Therapeutics Development 24
Actelion Ltd 24
APT Therapeutics, Inc. 25
Arena Pharmaceuticals, Inc. 26
Asahi Kasei Pharma Corp. 27
Ascendis Pharma A/S 28
Bial – Portela & Ca, S.A. 29
Cardioxyl Pharmaceuticals, Inc. 30
Carolus Therapeutics, Inc. 31
Celladon Corporation 32
Celsion Corporation 33
Corridor Pharmaceuticals Inc. 34
Cytokinetics, Inc. 35
Eli Lilly and Company 36
Gilead Sciences, Inc. 37
HanAll Biopharma Co., Ltd. 38
Insmed Incorporated 39
Ironwood Pharmaceuticals, Inc. 40
Lacer, S.A. 41
Longevity Biotech, Inc 42
LTT Bio-Pharma Co., Ltd. 43
Mast Therapeutics, Inc. 44
Mezzion Pharma Co. Ltd. 45
miRagen Therapeutics, Inc. 46
Nippon Shinyaku Co., Ltd. 47
Novartis AG 48
PharmaIN Corporation 49
PhaseBio Pharmaceuticals, Inc. 50
Pluristem Therapeutics Inc. 51
Proteo, Inc. 52
Reata Pharmaceuticals, Inc. 53
Sagene Pharmaceuticals, Inc. 54
Silence Therapeutics plc 55
Sinoxa Pharma GmbH 56
Suda Ltd 57
Therametrics holding AG 58
Toray Industries, Inc. 59
United Therapeutics Corporation 60
Pulmonary Arterial Hypertension – Therapeutics Assessment 61
Assessment by Monotherapy Products 61
Assessment by Combination Products 62
Assessment by Target 63
Assessment by Mechanism of Action 66
Assessment by Route of Administration 69
Assessment by Molecule Type 71
Drug Profiles 73
(allopurinol + apocynin) – Drug Profile 73
(chlorthalidone + valsartan) – Drug Profile 74
ACP-009 – Drug Profile 75
Antibody for Cancer and PAH – Drug Profile 76
Antibody for Pulmonary Arterial Hypertension – Drug Profile 77
APT-102 – Drug Profile 78
bardoxolone methyl – Drug Profile 80
beraprost sodium nanoparticles SR – Drug Profile 83
beraprost sodium SR – Drug Profile 84
BIA-51058 – Drug Profile 86
bosentan CR – Drug Profile 87
CT-2009 – Drug Profile 88
DasKloster-1000-01 – Drug Profile 89
Elafin – Drug Profile 91
esuberaprost sodium – Drug Profile 94
fasudil – Drug Profile 95
GS-4997 – Drug Profile 96
imatinib mesylate – Drug Profile 97
IW-1973 – Drug Profile 99
LA-419 – Drug Profile 100
lisuride – Drug Profile 101
macitentan – Drug Profile 103
Mydicar – Drug Profile 106
Oligonucleotide to Inhibit Endothelin-1 for Pulmonary Arterial Hypertension – Drug Profile 108
Oligonucleotide to Inhibit MicroRNA-145 for Pulmonary Arterial Hypertension – Drug Profile 109
PB-1046 – Drug Profile 110
PB-1120 – Drug Profile 112
Peptide to Antagonize Urotensin-II Receptor for PAH – Drug Profile 113
PGC-VIP – Drug Profile 114
PK-10453 – Drug Profile 115
R-190 – Drug Profile 116
ralinepag – Drug Profile 118
RNAi Oligonucleotide to Inhibit miR-145 for PAH – Drug Profile 120
selegiline + PDE-5 Inhibitor – Drug Profile 121
selexipag – Drug Profile 122
Small Molecule for Pulmonary Arterial Hypertension – Drug Profile 124
Small Molecule to Antagonize Notch Receptor for Pulmonary Arterial Hypertension and Hypoxia – Drug Profile 125
Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction – Drug Profile 126
Small Molecule to Inhibit Myosin for COPD, Asthma And Pulmonary Arterial Hypertension – Drug Profile 127
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension – Drug Profile 128
Small Molecules to Activate ACE2 for Pulmonary Arterial Hypertension – Drug Profile 129
Small Molecules to Antagonize 5-HT1B for Pulmonary Arterial Hypertension – Drug Profile 130
sodium nitrite – Drug Profile 131
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 133
SUD-004 – Drug Profile 135
Synthetic Peptide to Agonize VPAC2 for Pulmonary Arterial Hypertension – Drug Profile 136
tadalafil – Drug Profile 137
TPN-171 – Drug Profile 139
treprostinil diolamine – Drug Profile 140
TXA-127 – Drug Profile 141
udenafil – Drug Profile 143
Pulmonary Arterial Hypertension – Recent Pipeline Updates 145
Pulmonary Arterial Hypertension – Dormant Projects 168
Pulmonary Arterial Hypertension – Discontinued Products 169
Pulmonary Arterial Hypertension – Product Development Milestones 170
Featured News & Press Releases 170
Appendix 176
Methodology 176
Coverage 176
Secondary Research 176
Primary Research 176
Expert Panel Validation 176
Contact Us 176
Disclaimer 177
【レポート販売概要】
■ タイトル:肺動脈性肺高血圧症(Pulmonary Arterial Hypertension):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Pulmonary Arterial Hypertension - Pipeline Review, H1 2015
■ 発行日:2015年3月19日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6252IDB
■ 調査対象地域:グローバル
- 抗菌添加剤の世界市場分析:タイプ別(有機、無機)、用途別(プラスチック、塗料・コーティング、パルプ・紙)、エンドユーザー別(ヘルスケア、包装、食品・飲料、建設、自動車)、地域別、セグメント別、2014-2025The global antimicrobial additives market size is expected to reach USD 15.34 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for healthcare products such as medical devices and disposables in emerging economies including India and China will fuel growth over the forecast period. Furthermore, increasing awareness among consumers regarding hospital acquire …
- グローバル画像診断装置(医療機器)メーカー分析(技術能力、戦略、課題):AnalogicThe strategic assessment of Analogic, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in …
- モノマー市場動向:April 2013Monomer World - April 2013 Summary Global monomer prices continued their declining trend in April 2013, after monomer supply continued to increase in most regions. With the exception of the European ethylene market, monomer supplies were plentiful in comparison with demand. Prices declined both in the first and second halves of April. Scope - Analyses monthly price trends in Asia, Europe and North …
- スキンケア製品の世界市場分析:製品別(フェイスクリーム、ボディローション)、セグメント予測The global skin care products market size is expected to reach USD 196.67 billion by 2024, according to a new report by Grand View Research, Inc. The emergence and growth of e-commerce trading platforms and development of novel organic skin care solutions are expected to boost the market growth. The market offerings can be categorized on the basis of products into face cream and body lotion. Face …
- 世界のプロセス分析機器市場動向(2014-2018)TechNavio's analysts forecast the Global Process Analytical Instrumentation market to grow at a CAGR of 3.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to comply with stringent governmental regulations. The Global Process Analytical Instrumentation market has also been witnessing the emergence of technically advanced instruments. Howeve …
- 通信APIの世界市場予測(~2021年)“Increasing need for monetizing telecom carrier services is driving the smart education and learning market” The telecom Application Programming Interface (API) market size is estimated to grow from USD 93.69 billion in 2016 to USD 231.86 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 19.87%. Improving telecom API user experience, monetization of telecom operator services, rising dema …
- Oil Refineries Limited:石油・ガスバリューチェーン分析レポート2013Oil Refineries Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oil Refineries Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oil Refineries Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- リーシュマニア症(カラアザール病)(Leishmaniasis (Kala-Azar)):世界の治験レビュー(2015年上半期版)Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2015" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and …
- Clayton Williams Energy, Inc.:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- 大腸がんの世界市場展望2017-20276According to Stratistics MRC, the Global Colorectal Cancer Market is accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% during the forecast period. Introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations are some of the fact …
- オフロード車の世界市場2019-2023About this market Increasing outdoor recreational activities are benefiting the off-road vehicle market in regions such as North America and Europe. Mountain racing and dirt racing activities are gaining popularity amid a growing number of sports enthusiasts. The growth in tourism will promote off-recreational activities globally and requires governments to focus on developing tourism hubs, which …
- トルコの自動車用プラスチック配合の世界市場分析:製品別(ABS、PP、PU、PVC、PE、PC、PA、TPE)、用途別(インストルメントパネル、ドアシステム、内装部品、外装用看板、アンダーザフード部品)、セグメント予測、2014-2025Turkey automotive plastic compounding market is expected to reach USD 390.8 million by 2025, according to a new report by Grand View Research, Inc. Growing environmental concerns & stringent pollution control norms have compelled automotive OEMs to control emissions by utilizing innovative lightweight materials. The country’s automotive production increased from 1.17 million units to 1.35 million …
- スチレン・ブタジエンゴム(SBR)の世界市場:用途及び地域別分析The report covers the important styrene butadiene rubber global markets. It further divides the market on the basis of applications and geography. The market data for these types has been provided with respect to volume (thousand tons) and value ($million). The market value of styrene butadiene rubber was estimated to be $13,245 million in 2013 and is projected to grow at a CAGR of about 3.3% from …
- オフショア係留システムの世界市場分析:タイプ別(スプレッド、SPM、ダイナミック・ポジショニング、テンドン)、用途別(TLP、半潜水艦、SPAR、FPSO、ドリル船)、足場別、セグメント予測、2014-2025The global offshore mooring systems market is expected to reach USD 1.32 billion by 2025, according to a new report by Grand View Research, Inc. Increasing oil and gas production and exploration from the offshore fields rather than the onshore and the rising development of shale drilling regions for sustainable growth in future is expected to drive the demand for offshore mooring market. Innovatio …
- 世界のセキュリティソリューショング市場:提供別(製品(防火、ビデオ監視、アクセス制御)およびサービス(システム統合、リモート監視、防火、VSaaS、ACaaS))、業種別、地域別“The security solutions market is projected to grow at a CAGR of 9.0% from 2019 to 2024” The security solutions market was valued at USD 257.9 billion in 2019 and is projected to reach USD 397.6 billion by 2024; it is expected to grow at a CAGR of 9.0% during the forecast period. A few key factors driving the growth of this market include growing crime rates and terrorist activities globally, incr …